Literature DB >> 16551914

The delivery of drugs to patients by continuous intravenous infusion: modeling predicts potential dose fluctuations depending on flow rates and infusion system dead volume.

Mark A Lovich1, M Ellen Kinnealley, Nathanial M Sims, Robert A Peterfreund.   

Abstract

IV drug infusion has the potential for dosing errors, which arise from complex interactions between carrier flows and the infusion set dead volume. We computed the steady-state mass of drug stored in the infusion set dead volume, using phenylephrine as a model compound. The mass of drug in the dead volume increases with stock drug concentration and desired dose but decreases with carrier flow rate. We also modeled the dynamic perturbations in drug delivery when a carrier is abruptly stopped. Rapid initial carrier flow rates lead to greater depression in drug delivery rate after carrier flow ceases. Rapid drug infusion rates lead to faster restoration of desired drug delivery. Finally, the time to reach a new steady-state after a change in drug delivery or carrier rate was computed. This time is longest for large stock-drug concentrations, larger dead volumes, and slower final carrier rates. These computations illustrate that (a) the dead volume may contain a large mass of drug available for inadvertent bolus, (b) cessation of carrier flow can profoundly reduce drug delivery, and (c) after a change in carrier flow or drug dosing, a significant lag is possible before drug delivery achieves steady state. Although computed for phenylephrine, the concepts are generic and valid for any drug administered by IV infusion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16551914     DOI: 10.1213/01.ane.0000198670.02481.6b

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  11 in total

1.  Multiple Intravenous Infusions Phase 2b: Laboratory Study.

Authors:  Sonia Pinkney; Mark Fan; Katherine Chan; Christine Koczmara; Christopher Colvin; Farzan Sasangohar; Caterina Masino; Anthony Easty; Patricia Trbovich
Journal:  Ont Health Technol Assess Ser       Date:  2014-05-01

Review 2.  Essential elements of the native glucoregulatory system, which, if appreciated, may help improve the function of glucose controllers in the intensive care unit setting.

Authors:  Leon DeJournett
Journal:  J Diabetes Sci Technol       Date:  2010-01-01

3.  Can variable practice habits and injection port dead-volume put patients at risk?

Authors:  Michael T Kuntz; Roman Dudaryk; Richard R McNeer
Journal:  J Clin Monit Comput       Date:  2018-07-10       Impact factor: 2.502

4.  Multiple intravenous infusions phase 1b: practice and training scan.

Authors:  A Cassano-Piché; M Fan; S Sabovitch; C Masino; A C Easty
Journal:  Ont Health Technol Assess Ser       Date:  2012-05-01

5.  Delay and stability of central venous administration of norepinephrine in children: a bench study.

Authors:  Mehdi Oualha; Mikaël Capelo; Odile Spreux-Varoquaux; Isabelle Drouet-Chaillou; Jean-Marc Tréluyer; Philippe Hubert; Fabrice Lesage
Journal:  Eur J Pediatr       Date:  2013-08-11       Impact factor: 3.183

6.  Predictors of haemodynamic instability during the changeover of norepinephrine infusion pumps.

Authors:  Martin Cour; Thomas Bénet; Romain Hernu; Marie Simon; Thomas Baudry; Philippe Vanhems; Laurent Argaud
Journal:  Ann Intensive Care       Date:  2016-04-22       Impact factor: 6.925

7.  Analytical method for calculation of deviations from intended dosages during multi-infusion.

Authors:  Maurits K Konings; Roland A Snijder; Joris H Radermacher; Annemoon M Timmerman
Journal:  Biomed Eng Online       Date:  2017-01-17       Impact factor: 2.819

8.  Comparison of flow pressures in different 3-way infusion devices: an in-vitro study.

Authors:  Jonathan Chua; Arun Ratnavadivel
Journal:  Patient Saf Surg       Date:  2018-06-29

9.  Pharmacists in Critical Care.

Authors:  A K Mohiuddin
Journal:  Innov Pharm       Date:  2019-08-31

Review 10.  Reducing medication errors in critical care: a multimodal approach.

Authors:  Rachel M Kruer; Andrew S Jarrell; Asad Latif
Journal:  Clin Pharmacol       Date:  2014-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.